Home » Stocks » THMO

ThermoGenesis Holdings, Inc. (THMO)

Stock Price: $2.75 USD -0.07 (-2.48%)
Updated Jun 16, 2021 10:20 AM EDT - Market open
Market Cap 34.66M
Revenue (ttm) 8.06M
Net Income (ttm) -14.16M
Shares Out 11.45M
EPS (ttm) -1.84
PE Ratio n/a
Forward PE 2.29
Dividend n/a
Dividend Yield n/a
Trading Day June 16
Last Price $2.75
Previous Close $2.82
Change ($) -0.07
Change (%) -2.48%
Day's Open 2.78
Day's Range 2.72 - 2.80
Day's Volume 22,389
52-Week Range 1.92 - 7.50

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Which Reddit penny stocks are investors watching right now? Check these 3 out The post 3 Penny Stocks on Reddit Making Big Waves Right Now appeared first on Penny Stocks to Buy, Picks, News and Informat...

Other stocks mentioned: APM, LODE
3 weeks ago - PennyStocks

Shares of ThermoGenesis Holdings (NASDAQ:THMO) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 85.59% year over year to ($0.16), whi...

1 month ago - Benzinga

RANCHO CORDOVA, Calif., May 13, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, toda...

1 month ago - PRNewsWire

Low float stocks can be some of the most volatile stocks in the market. If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme.

Other stocks mentioned: RXDX, VYNT
1 month ago - Benzinga

RANCHO CORDOVA, Calif., May 6, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today...

1 month ago - PRNewsWire

RANCHO CORDOVA, Calif., March 17, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, to...

2 months ago - PRNewsWire

RANCHO CORDOVA, Calif., March 10, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, to...

3 months ago - PRNewsWire

RANCHO CORDOVA, Calif., Feb. 17, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. ("ThermoGenesis" or the "Company") (Nasdaq: THMO), a market leader in automated cell processing tools and services in t...

3 months ago - PRNewsWire

ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

RANCHO CORDOVA, Calif., Nov. 12, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, tod...

7 months ago - PRNewsWire

Health care stocks levered to blood collection and sampling, and plasma therapy biopharma companies are getting a big boost Monday after the FDA issued emergency use authorization for the use of investi...

Other stocks mentioned: ADMA, CERS, GRFS, KMDA, LMNL, SONN, TTOO
9 months ago - Benzinga

ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q2 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

RANCHO CORDOVA, Calif., Aug. 14, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc.

10 months ago - PRNewsWire

RANCHO CORDOVA, Calif., Aug. 11, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc.

10 months ago - PRNewsWire

ThermoGenesis Holdings: Many Short-Term Catalysts In Low-Float Stock

10 months ago - Seeking Alpha

RANCHO CORDOVA, Calif., June 23, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ann...

11 months ago - PRNewsWire

RANCHO CORDOVA, Calif., June 8, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, anno...

1 year ago - PRNewsWire

RANCHO CORDOVA, Calif., May 28, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, toda...

1 year ago - PRNewsWire

ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

RANCHO CORDOVA, Calif., May 14, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, toda...

1 year ago - PRNewsWire

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

Other stocks mentioned: BDTX, NERV, SPT, ZYXI
1 year ago - Zacks Investment Research

As of late, it has definitely been a great time to be an investor in ThermoGenesis Holdings, Inc. (THMO).

1 year ago - Zacks Investment Research

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

Other stocks mentioned: CUE, LVGO, SMED, VNET
1 year ago - Zacks Investment Research

Thermogenesis Holdings Inc (NASDAQ: THMO) shares are trading higher on Thursday.

1 year ago - Benzinga

ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

The Reincarnation Of ThermoGenesis With A Better Mousetrap For CAR-T Manufacturing

1 year ago - Seeking Alpha

About THMO

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automa... [Read more...]

Industry
Medical Devices
Founded
1986
CEO
Xiaochun Xu
Employees
40
Stock Exchange
NASDAQ
Ticker Symbol
THMO
Full Company Profile

Financial Performance

In 2020, THMO's revenue was $9.74 million, a decrease of -25.32% compared to the previous year's $13.05 million. Losses were -$16.35 million, 72.2% more than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for THMO stock is "Buy" and the 12-month stock price forecast is 6.00.

Price Target
$6.00
Analyst Consensus: Buy